News

Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth

by

DUBLIN, May 16, 2023 /PRNewswire/ — The “Asia-Pacific Next-generation Diagnostics Outlook, 2023” report has been added to  ResearchAndMarkets.com’s offering. The Asia-Pacific next-generation diagnostics market’s revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient … Read more

China Vitamin C E-commerce Market Data Subscription 2023

by

DUBLIN, May 16, 2023 /PRNewswire/ — The “2023 Vitamin C – Douyin, China E-commerce Market Data Subscription” database has been added to  ResearchAndMarkets.com’s offering. This database subscription gives you all the information you need on the market for Vitamin C supplements in the Chinese market, as measured on the Douyin platform. The data subscription service … Read more

Lateral Flow Assay Components Market size to grow by USD 97.76 million from 2022 to 2027; Growth driven by rising efforts in research and development- Technavio

by

NEW YORK, May 16, 2023 /PRNewswire/ — The lateral flow assay components market size is set to grow by USD 97.76 million from 2022 to 2027 progressing at a CAGR of 5.22% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market … Read more

Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density

by

SUZHOU, China, May 16, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces encouraging phase I clinical data of TST002 (Blosozumab) in Chinese patients with reduced bone mineral density (BMD). TST002 (Blosozumab) was well tolerated and significantly … Read more

Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings

by

ROCKVILLE, Md. and SUZHOU, China, May 16, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today announces that about 30 accepted abstracts of clinical data from multiple trials in relation to … Read more

Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia

by

SHANGHAI, May 16, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment in a multi-center Phase 3 clinical trial of etrasimod in Asia for the treatment of moderate-severe active ulcerative colitis … Read more

La FDA aprobó un nuevo medicamento para tratar los sofocos moderados a graves causados por la menopausia

by

In English  SILVER SPRING, Md., 16 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/– La Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) aprobó Veozah (fezolinetant), un medicamento oral para el tratamiento de síntomas vasomotores moderados a graves, o sofocos, causados por la menopausia. Veozah es el primer antagonista del receptor … Read more

Fresh2 Reports Fiscal Year 2022 Annual Financial Results

by

NEW YORK, May 16, 2023 /PRNewswire/ — Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,”Fresh2,” the “Company” or “we”) (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale … Read more

Vial Welcomes New VP of Operations, Ankit Agarwal

by

SAN FRANCISCO, May 16, 2023 /PRNewswire/ — Vial, a global tech-driven CRO providing next-generation clinical trial management services, has added Ankit Agarwal to their team. Agarwal will be the company’s new VP of Operations. Agarwal joins the team with over 10 years of experience in strategy and operations. He has worked in both large multinational … Read more

Quest Diagnostics Declares Quarterly Cash Dividend

by

SECAUCUS, N.J., May 16, 2023 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.71 per share, payable on July 25, 2023 to shareholders of record of Quest Diagnostics common stock on July 11, 2023. About Quest DiagnosticsQuest Diagnostics empowers people to take action … Read more